Kasraian L, Nikeghbalian S, Karimi M H
Blood Transfusion Research Center, Higher Institute for Research and Education in Transfusion Medicine, Tehran, Iran.
Department of Hepatobiliary and Transplantation Surgery, Shiraz University of Medical Sciences, Shiraz Transplant Center, Shiraz, Iran.
Int J Organ Transplant Med. 2018;9(3):105-111. Epub 2018 Aug 1.
Estimation of the amount of blood products required during liver transplantation can help provision of adequate blood supply, minimize transfusion-associated complications, and plan for preventive measures in high risk patients.
To investigate independent predictors of peri-operative blood product transfusion and its impact on short-term survival of liver transplant recipients.
In a cross-sectional study, old charts of patients who underwent liver transplantation between March 2003 and March 2013 at Namazi Hospital, Shiraz, Iran, were reviewed. The mean amount of blood product utilized during surgery and hospital stay and the related factors, including demographic characteristics, pre-transplant laboratory data, pre-transplant clinical data, operation data, and post-transplantation data were recorded.
We studied 1198 patients who underwent liver transplantation. The mean±SD amounts of red blood cells, fresh frozen plasma, and platelet transfusion during surgery and hospital stay were 2.67±3.5, 2.06±3.8, and 1.6±3.8 units, respectively. The mortality rate was significantly higher in patients who received high amounts of blood products (p<0.001). The mean amount of blood products' utilized during operation was significantly (p<0.001) decreased from 2003 to 2013.The mean amount of packed cell usage during operation and hospital stay was significantly (p<0.001) correlated with age, technique of surgery, serum albumin level, cirrhosis, blood urea nitrogen, length of operation, and prothrombin time.
Pre-operative factors may predict blood transfusion requirements in patients undergoing liver transplantation. Therefore, evaluation of patients before operation should be considered to provide adequate blood supply and minimize transfusion-associated complications. Understanding pre-operative factors associated with rate of transfusion may help us to best utilize the limited available blood resources.
估计肝移植期间所需血液制品的数量有助于提供充足的血液供应,将输血相关并发症降至最低,并为高危患者制定预防措施。
探讨围手术期血液制品输血的独立预测因素及其对肝移植受者短期生存的影响。
在一项横断面研究中,回顾了2003年3月至2013年3月在伊朗设拉子纳马齐医院接受肝移植患者的旧病历。记录手术和住院期间使用的血液制品的平均数量以及相关因素,包括人口统计学特征、移植前实验室数据、移植前临床数据、手术数据和移植后数据。
我们研究了1198例接受肝移植的患者。手术和住院期间红细胞、新鲜冰冻血浆和血小板输注的平均±标准差数量分别为2.67±3.5、2.06±3.8和1.6±3.8单位。接受大量血液制品的患者死亡率显著更高(p<0.001)。2003年至2013年期间,手术期间使用的血液制品平均数量显著下降(p<0.001)。手术和住院期间浓缩红细胞的使用平均数量与年龄、手术技术、血清白蛋白水平、肝硬化、血尿素氮、手术时间和凝血酶原时间显著相关(p<0.001)。
术前因素可能预测肝移植患者的输血需求。因此,应考虑在术前对患者进行评估,以提供充足的血液供应并将输血相关并发症降至最低。了解与输血率相关的术前因素可能有助于我们最佳利用有限的可用血液资源。